| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532296 |
NSE Symbol : GLENMARK |
P/E(TTM) : 22.97 |
|
ISIN Demat : INE935A01035 |
Div & Yield% : 0.16 |
EPS(TTM) : 67.15 |
|
Book Value(₹) : 848.58 |
Market Cap(₹Cr) : 43,523.29 |
Face Value(₹) : 1.00 |
| Board Of Directors | |
|---|---|
| Chairman & Managing Director |
Glenn Saldanha
|
| Executive Director & Group CFO |
V S Mani
|
| Executive Director (Corporate) |
Cheryl Pinto
|
| Independent Non Exe. Director |
Rajesh Desai.
Sona Saira Ramasastry
Dipankar Bhattacharjee
V R Iyer
|
| Non Executive Director |
B E Saldanha
|